Log in to see the prices.
The price above is a net price.
The Giardia intestinalis (qPCR) product is used to detect sequences specific to the protozoan Giardia intestinalis in DNA preparations obtained from human feces.
Kit size: 100 reactions
Reaction: duplex (FAM: Giardia intestinalis, HEX: internal control)
Internal control: exogenous/endogenous
Determination: qualitative/quantitative
Kit components:
The protozoan Giardia intestinalis (syn. Giardia lamblia and Giardia duodenalis) is one of the most common intestinal parasites in humans. Approximately 200 million people in Asia, Africa, and Latin America suffer from symptomatic infections. Approximately 500,000 new cases are reported annually. After infection, G. intestinalis generally causes a self-limiting clinical disease (i.e. giardiasis) characterized by diarrhea, abdominal cramps, bloating, weight loss, and malabsorption. However, asymptomatic giardiasis is common, especially in developing countries.
Giardia protozoa are also very common intestinal parasites in domestic animals, including livestock, dogs, cats, and wild animals. Giardia intestinalis causes giardiasis not only in humans but also in most mammals. Therefore, this disease is considered a zoonotic disease.
Giardiasis has a significant impact on public health due to its high prevalence and ability to cause serious outbreaks. Long-term infection has a negative impact on the growth and cognitive functions of infected children. Infections with Giardia protozoa are also common in livestock and companion animals. Infections are often asymptomatic, but they may be associated with diarrhea and poor condition in calves, puppies, and kittens. Giardiasis in animals is associated with economic losses due to diarrhea, poor growth, and even death in livestock.
Treating giardiasis requires the use of antiparasitic medicines. The most commonly used drug is metronidazole, which effectively eliminates the parasite from the body. An alternative to this drug is tinidazole, which is similarly effective.
